Healthcare - Biotechnology - NASDAQ - US
$ 56.62
-6.18 %
$ 2.29 B
Market Cap
-10.85
P/E
Price Target
Average
80.15%
Revenue Forecast
Estimate
522.19%
EBIT
Estimate
28.16%
Net Income
Estimate
12.90%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Keros Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for KROS of $102 , with forecasts ranging from a low of $96 to a high of $107 .
KROS Lowest Price Target
Wall Street Target
96 USD
69.55%
KROS Average Price Target
Wall Street Target
102 USD
80.15%
KROS Highest Price Target
Wall Street Target
107 USD
88.98%
REVENUE FORECAST
Revenue Forecast Chart KROS
EBIT FORECAST
EBIT Forecast Chart KROS
NET INCOME FORECAST
Net Income Chart KROS